Amphastar expands board to 10, appoints CFO Peters and EVP Liawatidewi as directors

Amphastar Pharmaceuticals, Inc.

Board size increased from 8 to 10, effective August 4, 2022.
William J. Peters (CFO, EVP Finance, Treasurer) appointed as Class I director.
Jacob Liawatidewi (EVP Corporate Administration & Sales/Marketing) appointed as Class I director.
Diane G. Gerst deemed independent; now six of ten directors are independent.
No changes to existing compensatory arrangements for the new directors.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

William J. Peters

Class I Director

AMPH · Amphastar Pharmaceuticals, Inc.

Effective: 2022-08-04
Filed: August 9, 2022, 7:59 PM ET

appointed each of William J. Peters, the Company’s Chief Financial Officer, Executive Vice President of Finance, and Treasurer, and Jacob Liawatidewi, the Company’s Executive Vice President of Corporate Administration Center, and Sales and Marketing (together with Mr. Peters, the “New Directors”), to serve as Class I directors

Appointed

Jacob Liawatidewi

Class I Director

AMPH · Amphastar Pharmaceuticals, Inc.

Effective: 2022-08-04
Filed: August 9, 2022, 7:59 PM ET

appointed each of William J. Peters, the Company’s Chief Financial Officer, Executive Vice President of Finance, and Treasurer, and Jacob Liawatidewi, the Company’s Executive Vice President of Corporate Administration Center, and Sales and Marketing (together with Mr. Peters, the “New Directors”), to serve as Class I directors

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

William J. Peters was appointed as Class I Director at Amphastar Pharmaceuticals, Inc..

Action: appointed
Role: Class I Director

Exact text from the filing

appointed each of William J. Peters, the Company’s Chief Financial Officer, Executive Vice President of Finance, and Treasurer, and Jacob Liawatidewi, the Company’s Executive Vice President of Corporate Administration Center, and Sales and Marketing (together with Mr. Peters, the “New Directors”), to serve as Class I directors

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jacob Liawatidewi was appointed as Class I Director at Amphastar Pharmaceuticals, Inc..

Action: appointed
Role: Class I Director

Exact text from the filing

appointed each of William J. Peters, the Company’s Chief Financial Officer, Executive Vice President of Finance, and Treasurer, and Jacob Liawatidewi, the Company’s Executive Vice President of Corporate Administration Center, and Sales and Marketing (together with Mr. Peters, the “New Directors”), to serve as Class I directors

View on SEC.gov

Amphastar Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001297184-22-000048

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.